Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shakes aim to fight malnutrition in adults

NCT ID NCT05257980

Disease control Sponsor: Nutricia UK Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests four new ready-to-drink nutritional supplements in 100 adults who are malnourished or at risk. Participants take one of the supplements daily for 28 days alongside their usual diet. Researchers track how well people stick with the drink, their nutrient intake, and any stomach discomfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
oral nutritional supplement (ONS)
What this could lead to
If successful, these supplements could offer better-tolerated options to help malnourished adults improve their nutrient intake and nutritional status.
What could go wrong
This is a small, short-term study (100 participants, 28 days) with no blinding or placebo, so results may not apply broadly or show long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2021

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * ≥16 years of age * Identified as being malnourished/at risk of malnutrition by malnutrition screening tools \[i.e., MUST score ≥1, and/or using or requiring ONS at least once daily as part of nutritional management plan\] * Expected to receive at least one bottle of ONS per day * Written or electronic informed consent from patient, or verbally given consent countersigned by a witness for those physically unable to sign Exclusion Criteria: * Patients receiving parenteral nutrition or ≥70% total energy requirements from enteral tube feeding * Patients with major hepatic dysfunction (i.e., decompensated liver disease) * Patients with major renal dysfunction \[i.e., requiring filtration or stage 4/5 chronic kidney disease (CKD)\] * Cancer patients likely to anticipate significant gastrointestinal disturbances/taste changes as a result of Systemic Anti-Cancer Therapy (SACT) * Patients with active/chronic gastrointestinal disease or impaired gastrointestinal function * Patients with significant dysphagia/high aspiration risk * Participation in other clinical intervention studies within 1 month of this study * Adults lacking mental capacity to consent * Allergy to any study product ingredients * Investigator concern regarding ability or willingness of patient to comply with the study requirements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malnutrition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Malnutrition nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malnutrition

Contacts and locations

Locations

  • Airedale NHS Foundation Trust

    Keighley, United Kingdom

  • Ashford and St Peter's Hospitals NHS Foundation Trust

    Ashford, United Kingdom

  • Cowplain Family Practice

    Waterlooville, United Kingdom

  • Glan Clwyd Hospital

    Rhyl, United Kingdom

  • Honiton Surgery

    Honiton, United Kingdom

  • James Alexander Family Practice

    Hull, United Kingdom

  • Kings Cross Hospital

    London, United Kingdom

  • Mountainhall Treatment Centre

    Dumfries, United Kingdom

  • NHS Highland

    Inverness, United Kingdom

  • Norfolk Community Health and Care NHS Trust

    Norwich, United Kingdom

  • Northumbria Healthcare NHS Foundation Trust

    Newcastle, United Kingdom

  • Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom

  • Preston Hill Surgery

    Harrow, United Kingdom

  • Rowden Surgery

    Chippenham, United Kingdom

  • Royal Surrey NHS Foundation Trust

    Guildford, United Kingdom

  • Sirona Care & Health

    Clevedon, United Kingdom

  • Trowbridge Health Centre

    Trowbridge, United Kingdom

  • West Walk Surgery

    Bristol, United Kingdom

  • Yeovil District Hospital

    Yeovil, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.